Cargando…
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy
Sickle cell disease (SCD) is a worldwide distributed hereditary red cell disorder characterized by recurrent acute vaso-occlusive crises (VOCs and anemia). Gold standard treatments are hydroxycarbamide (HC) and/or different red blood cell (RBC) transfusion regimens to limit disease progression. Here...
Ejemplares similares
-
Management of the Sickle Cell Trait: An Opinion by Expert Panel Members
por: Pinto, Valeria Maria, et al.
Publicado: (2023) -
Current challenges in the management of patients with sickle cell disease – A report of the Italian experience
por: Russo, Giovanna, et al.
Publicado: (2019) -
Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm
por: Baronciani, Donatella, et al.
Publicado: (2021) -
Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting
por: Pinto, Valeria Maria, et al.
Publicado: (2022) -
Influenza Vaccination in Asplenia: Improving Quality of Care in Time of Coronavirus
por: Di Maio, Nicoletta, et al.
Publicado: (2020)